ADHF Pathophysiology and Emerging Devices (DRIIPPS)
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Sequana Medical AG; Owkin; Relypsa Inc; preCARDIA Inc; Cardiol Therapeutics Inc; Genomics plc
- Grant Support/Research Contract (Institutional) - Alnylam Pharmaceuticals; Pfizer Inc / Array Biopharma; 3Live, Inc; SalubrisBio; Second Heart; Bristol-Myers Squibb
- Consultant Fee/Honoraria/Speaker's Bureau (Institutional) - Applied Therapeutics Inc